PBM reform, Medicare Advantage exits, and the 340B rebate pilot are reshaping drug access. Here is what payers need to know heading into 2027.
|Articles|April 24, 2012
If Supreme Court Rejects Obama's Health Law, Employers, Insurers will Drive Their Own Overhaul
Advertisement
If the Supreme Court strikes down President Barack Obama's health care law, employers and insurance companies — not the government — will be the main drivers of change over the next decade and maybe even longer.
They'll borrow some ideas from Obamacare, and push harder to cut costs.
Read the full story:
Source: Chicago Tribune
Advertisement
Related to this article
The GOLD International COPD Conference will cover underdiagnosis, exacerbations, mucus, biologics, and a preview of the 2027 GOLD Report.
People with multiple sclerosis make up most of a survey linking variable-friction footwear to fewer self-reported falls.
Clinicians at an AJMC roundtable in Cleveland said Medicare's GLP-1 Bridge came late and that cost and capacity gaps persist.
Nathan Estrada, DPT, explains which patients, including those with multiple sclerosis, may benefit from footwear that adapts to gait.
Patients with Sjögren disease have 5-fold higher odds of depression, yet screening tools remain unvalidated, a new review finds.
Medicare Advantage exits, rising ACA premiums, a Medicare for America bill, and a Medicaid work rule ruling frame health policy on Election Day.
Patient selection raised detection of pathogenic germline variants from 6% to 27% in lung cancer studies.
Advertisement
Advertisement
Trending on AJMC
1
First-Line Vitiligo Treatment: Topical JAK Inhibitors and Phototherapy
2
Unanswered Questions in First- and Second-Line mCRC Care
3
Cleveland Clinicians Say Obesity Care Starts Too Late for Many Patients
4
Precision Drugs Meet Payer Realities
5